TheraRadar

Pharma Intelligence, Simplified

Company Portfolios →

Jiangsu Hansoh Pharmaceutical Co., Ltd.

37 active trials across 8 therapeutic areas

37
Active Trials
27
Phase 1
6
Phase 2
6
Phase 3
8
Therapeutic Areas
Portfolio Concentration: 92% of active trials in Oncology

Oncology

34 active / 35 total
NSCLC
11 active 3 Ph3
11 total since 2015
Solid Tumor (Advanced)
6 active
7 total since 2015
CML
3 active
3 total since 2015
Renal Cell Carcinoma
2 active
2 total since 2015
Ovarian Cancer
2 active
2 total since 2015
Breast Cancer
2 active
2 total since 2015
Colorectal Cancer
2 active
2 total since 2015
Lung Cancer (General)
1 active
1 total since 2015
Triple Negative Breast Cancer
1 active
1 total since 2015
Prostate Cancer
1 active
1 total since 2015
Gastric Cancer
1 active
1 total since 2015
Pancreatic Cancer
1 active
1 total since 2015
SCLC
1 active
1 total since 2015

Metabolic

5 active / 8 total
Type 2 Diabetes
2 active 2 Ph3
5 total since 2015
Obesity
2 active 1 Ph3
2 total since 2015
Dyslipidemia
1 active
1 total since 2015

Immunology

2 active / 3 total
Psoriasis
2 active
3 total since 2015

Infectious Disease

1 active / 2 total
Hepatitis B
1 active
2 total since 2015

Women's Health

1 active / 1 total
Endometriosis
1 active
1 total since 2015

CNS

0 active / 2 total
Major Depression
0 active
2 total since 2015

Musculoskeletal

0 active / 1 total
Osteoarthritis
0 active
1 total since 2015

Renal

0 active / 1 total
Chronic Kidney Disease
0 active
1 total since 2015

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)